Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 2
2006 2
2007 1
2008 1
2009 1
2010 1
2011 3
2012 8
2013 5
2014 3
2015 7
2016 6
2017 2
2018 2
2019 2
2020 5
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year
Filters applied: . Clear all
Page 1
Dysregulated mesenchymal PDGFR-β drives kidney fibrosis.
Buhl EM, Djudjaj S, Klinkhammer BM, Ermert K, Puelles VG, Lindenmeyer MT, Cohen CD, He C, Borkham-Kamphorst E, Weiskirchen R, Denecke B, Trairatphisan P, Saez-Rodriguez J, Huber TB, Olson LE, Floege J, Boor P. Buhl EM, et al. Among authors: borkham kamphorst e. EMBO Mol Med. 2020 Mar 6;12(3):e11021. doi: 10.15252/emmm.201911021. Epub 2020 Jan 14. EMBO Mol Med. 2020. PMID: 31943786 Free PMC article.
The PDGF system and its antagonists in liver fibrosis.
Borkham-Kamphorst E, Weiskirchen R. Borkham-Kamphorst E, et al. Cytokine Growth Factor Rev. 2016 Apr;28:53-61. doi: 10.1016/j.cytogfr.2015.10.002. Epub 2015 Oct 30. Cytokine Growth Factor Rev. 2016. PMID: 26547628 Review.
BMP-7 as antagonist of organ fibrosis.
Weiskirchen R, Meurer SK, Gressner OA, Herrmann J, Borkham-Kamphorst E, Gressner AM. Weiskirchen R, et al. Among authors: borkham kamphorst e. Front Biosci (Landmark Ed). 2009 Jun 1;14(13):4992-5012. doi: 10.2741/3583. Front Biosci (Landmark Ed). 2009. PMID: 19482601 Free article. Review.
Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver.
Buniatian GH, Weiskirchen R, Weiss TS, Schwinghammer U, Fritz M, Seferyan T, Proksch B, Glaser M, Lourhmati A, Buadze M, Borkham-Kamphorst E, Gaunitz F, Gleiter CH, Lang T, Schaeffeler E, Tremmel R, Cynis H, Frey WH 2nd, Gebhardt R, Friedman SL, Mikulits W, Schwab M, Danielyan L. Buniatian GH, et al. Among authors: borkham kamphorst e. Cells. 2020 Feb 17;9(2):452. doi: 10.3390/cells9020452. Cells. 2020. PMID: 32089540 Free PMC article.
α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin.
Schwinghammer UA, Melkonyan MM, Hunanyan L, Tremmel R, Weiskirchen R, Borkham-Kamphorst E, Schaeffeler E, Seferyan T, Mikulits W, Yenkoyan K, Schwab M, Danielyan L. Schwinghammer UA, et al. Among authors: borkham kamphorst e. Cells. 2020 Feb 18;9(2):456. doi: 10.3390/cells9020456. Cells. 2020. PMID: 32085378 Free PMC article.
Identification of Pparγ-modulated miRNA hubs that target the fibrotic tumor microenvironment.
Winkler I, Bitter C, Winkler S, Weichenhan D, Thavamani A, Hengstler JG, Borkham-Kamphorst E, Kohlbacher O, Plass C, Geffers R, Weiskirchen R, Nordheim A. Winkler I, et al. Among authors: borkham kamphorst e. Proc Natl Acad Sci U S A. 2020 Jan 7;117(1):454-463. doi: 10.1073/pnas.1909145117. Epub 2019 Dec 23. Proc Natl Acad Sci U S A. 2020. PMID: 31871210 Free PMC article.
Lipocalin-2 (NGAL/LCN2), a "help-me" signal in organ inflammation.
Asimakopoulou A, Borkham-Kamphorst E, Tacke F, Weiskirchen R. Asimakopoulou A, et al. Among authors: borkham kamphorst e. Hepatology. 2016 Feb;63(2):669-71. doi: 10.1002/hep.27930. Epub 2015 Jul 31. Hepatology. 2016. PMID: 26054053 No abstract available.
The role of PDGF-D in healthy and fibrotic kidneys.
Buhl EM, Djudjaj S, Babickova J, Klinkhammer BM, Folestad E, Borkham-Kamphorst E, Weiskirchen R, Hudkins K, Alpers CE, Eriksson U, Floege J, Boor P. Buhl EM, et al. Among authors: borkham kamphorst e. Kidney Int. 2016 Apr;89(4):848-61. doi: 10.1016/j.kint.2015.12.037. Epub 2016 Feb 18. Kidney Int. 2016. PMID: 26924050 Free article.
45 results